Arcturus Therapeutics Holdings Inc. (ARCT) Total Assets by Year
Arcturus Therapeutics Holdings Inc. closed fiscal year 2025 with $271.1M in total assets, $57.2M in total liabilities and $214.0M in shareholder equity. This represents a decrease of 21.2% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Arcturus Therapeutics Holdings Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ARCT Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $271.1M-21.2% | $344.1M-19.9% | $429.4M-4.7% | $450.4M+14.7% | $392.8M-17.6% | $476.5M+480.0% | $82.1M+85.9% | $44.2M |
| Total Liabilities | $57.2M-44.6% | $103.1M-31.7% | $150.9M-16.2% | $180.1M+9.4% | $164.6M+106.0% | $79.9M+41.8% | $56.4M+84.4% | $30.6M |
| Total Equity | $214.0M-11.2% | $241.0M-13.5% | $278.5M+3.0% | $270.3M+18.4% | $228.2M-42.5% | $396.6M+1437.5% | $25.8M+89.1% | $13.6M |
ARCT Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $224.3M-27.5% | $245.4M-26.0% | $271.1M-21.2% | $282.3M-23.8% | $309.3M-20.4% | $331.8M-20.8% | $344.1M-19.9% | $370.7M-19.0% | $388.6M-9.8% | $418.8M-11.0% | $429.4M-4.7% | $457.6M+55.9% |
| Total Liabilities | $52.5M-32.9% | $54.0M-44.9% | $57.2M-44.6% | $57.8M-46.9% | $78.2M-39.8% | $98.0M-36.7% | $103.1M-31.7% | $108.8M-38.7% | $130.0M-10.6% | $154.9M+9.4% | $150.9M-16.2% | $177.6M+20.0% |
| Total Equity | $171.8M-25.6% | $191.4M-18.1% | $214.0M-11.2% | $224.6M-14.2% | $231.1M-10.6% | $233.8M-11.4% | $241.0M-13.5% | $261.9M-6.5% | $258.6M-9.3% | $264.0M-19.8% | $278.5M+3.0% | $280.1M+92.3% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Arcturus Therapeutics Holdings Inc. financials
Frequently Asked Questions
What was Arcturus Therapeutics Holdings Inc.'s total assets in fiscal year 2025?
Arcturus Therapeutics Holdings Inc. closed fiscal year 2025 with $271.1M in total assets, $57.2M in total liabilities and $214.0M in shareholder equity.
How fast is Arcturus Therapeutics Holdings Inc.'s total assets growing?
Arcturus Therapeutics Holdings Inc. (ARCT) total assets fell by 21.2% year over year, from $344.1M to $271.1M in fiscal year 2025.
How has Arcturus Therapeutics Holdings Inc.'s total assets changed over the years?
Across the 8 fiscal years this page covers, Arcturus Therapeutics Holdings Inc. (ARCT) total assets went from $44.2M in fiscal year 2018 to $271.1M in fiscal year 2025.
What was Arcturus Therapeutics Holdings Inc.'s total assets in the most recent quarter?
Arcturus Therapeutics Holdings Inc. (ARCT) reported $224.3M in total assets in Q2 2026. This represents a decrease of 27.5% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Arcturus Therapeutics Holdings Inc. (ARCT) reported on that line in every period on record.